Mutations in Parkinsonism-linked endocytic proteins synaptojanin1 and auxilin have synergistic effects on dopaminergic axonal pathology.
Xin Yi NgYumei WuYouneng LinSidra Mohamed YaqoobLois E GreenePietro De CamilliMian CaoPublished in: NPJ Parkinson's disease (2023)
Parkinson's disease (PD) is a neurodegenerative disorder characterized by defective dopaminergic (DAergic) input to the striatum. Mutations in two genes encoding synaptically enriched clathrin-uncoating factors, synaptojanin 1 (SJ1) and auxilin, have been implicated in atypical Parkinsonism. SJ1 knock-in (SJ1-KI RQ ) mice carrying a disease-linked mutation display neurological manifestations reminiscent of Parkinsonism. Here we report that auxilin knockout (Aux-KO) mice display dystrophic changes of a subset of nigrostriatal DAergic terminals similar to those of SJ1-KI RQ mice. Furthermore, Aux-KO/SJ1-KI RQ double mutant mice have shorter lifespan and more severe synaptic defects than single mutant mice. These include increase in dystrophic striatal nerve terminals positive for DAergic markers and for the PD risk protein SV2C, as well as adaptive changes in striatal interneurons. The synergistic effect of the two mutations demonstrates a special lability of DAergic neurons to defects in clathrin uncoating, with implications for PD pathogenesis in at least some forms of this condition.
Keyphrases
- high fat diet induced
- wild type
- parkinson disease
- disease activity
- drug induced
- spinal cord injury
- rheumatoid arthritis
- insulin resistance
- spinal cord
- squamous cell carcinoma
- early onset
- neoadjuvant chemotherapy
- type diabetes
- radiation therapy
- cancer therapy
- functional connectivity
- systemic lupus erythematosus
- brain injury
- blood brain barrier
- peripheral nerve
- subarachnoid hemorrhage
- amino acid